We found that the tumor growth was significantly inhibited in the mice treated with the MUT-Mtmr10 and MUT-Msatl neoantigen-adjuvant vaccines, but not with other four neoantigen-adjuvant vaccines, compared to that of the PBS and adjuvant-alone treatment groups (P < 0.05) (Fig. 2a, b). This evidence concerns the gene MTMR10 and neoplasm.